NEWS CENTER

Blog

About Jiangsu Feiyu Pharmaceutical Technology Co., Ltd. Listing Guidance Filing Information Publicity


Release time:

2021/07/21

Jiangsu Feiyu Pharmaceutical Technology Co., Ltd. plans to issue RMB common shares for the first time and list on the gem. It is now receiving the guidance of Changjiang Securities underwriting sponsor Co., Ltd.

Jiangsu Feiyu Pharmaceutical Technology Co., Ltd. plans to issue RMB common shares for the first time and list on the gem. It is now receiving the guidance of Changjiang Securities underwriting sponsor Co., Ltd.
In accordance with the relevant requirements of the China Securities Regulatory Commission, in order to improve the transparency of stock issuance and listing, prevent and resolve risks in the securities market, and protect the legitimate rights and interests of investors, the Company is willing to accept the supervision of public opinion from all walks of life and the public. The relevant contact information and reporting telephone number are announced as follows:
The sponsors of Jiangsu Feiyu Pharmaceutical Technology Co., Ltd. are Wu Yufei, Changzhou Yuzhong Industrial Investment Partnership (Limited Partnership), Zhang Yingjie, Lin Hefei and Bao Jianhua. The company's domicile is the basic chemical industry zone of Xingang District, Chunjiang Town, Changzhou City, Jiangsu Province. Its legal representative is Wu Yufei, its contact person is Liu Zhexi, its contact number is 0519-85286219, its fax number is 0519-81299810, and e-mail number is securities@jsfytech.com.cn. China Securities Regulatory Commission Jiangsu Regulatory Bureau report telephone number: 025-84575515, correspondence address: 19th floor, Huatai Securities Building, No. 90 Zhongshan East Road, Nanjing (zip code 210002).


It is hereby announced.

 

Board of Directors of Jiangsu Feiyu Pharmaceutical Technology Co., Ltd.
July 20, 2021